Orchid Pharma informs about company updates

31 Dec 2015

Orchid Pharma has informed that the company received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection closure for the formulation manufacturing facility located at Irungattukottai, Sriperumbudur, Kancheepuram District, India. The facility was inspected by USFDA in the month of May 2015.

The above information is a part of company’s filings submitted to BSE.

Related Orchid Pharma Ltd. Links:

Orchid Pharma Share Price

1024.60 48.75 (5.00%) Mar 03, 18:59
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 624.15
Dr. Reddys Lab 4500.80
Lupin 1060.85
Piramal Enterprises 1992.70
Cadila Healthcare 445.50
View more..
Sensex vs Orchid Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback